Quantity size:
0.2ml
Concentration:
1mg/ml 抑癌基因PDLIM4抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
RIL, also known as PDLIM4 is a putative tumor suppressor gene. RIL is transcriptionally repressed by hypermethylation in a variety of tumors including breast and prostate. The difference in methylation status of RIL between normal and cancerous tissues is bein抑癌基因PDLIM4抗体g investigated as to determine the use of RIL as a potential biomarker. Two isoforms of human RIL one have been identified.
抑癌基因PDLIM4抗体Also known as:
Enigma homolog; LIM domain protein; LIM protein RIL; PDLIM 4; PDLIM4; PDZ and LIM domain 4; PDZ and LIM domain protein 4; Reversion induced LIM protein; PDLI4_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG,抑癌基因PDLIM4抗体 affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human RIL.
●
Predicted Molecular Weight: 35kDa.
抑癌基因PDLIM4抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user
kl376Mu01辅肌动蛋白α2(ACTN2)多克隆抗体Polyclonal Antibody to Actinin Alpha 2 (ACTN2)
kl380Bo01血管活性肠肽(VIP)多克隆抗体Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl380Hu01血管活性肠肽(VIP)多克隆抗体Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl380Mu01血管活性肠肽(VIP)多克隆抗体Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl380Ra01血管活性肠肽(VIP)多克隆抗体Polyclonal Antibody to Vasoactive Intestinal Peptide (VIP)
kl382Hu01蛋白激酶Bγ(PKBγ)多克隆抗体Polyclonal Antibody to Protein Kinase B Gamma (PKBg)
kl383Hu01磷酸肌醇-3-激酶2α肽(PI3K2α)多克隆抗体Polyclonal Antibody to Phosphoinositide-3-Kinase Class-2-Alpha Polypeptide (PIK3C2a)
kl383Mu01磷酸肌醇-3-激酶2α肽(PI3K2α)多克隆抗体Polyclonal Antibody to Phosphoinositide-3-Kinase Class-2-Alpha Polypeptide (PIK3C2a)
kl384Hu01白介素23(IL23)多克隆抗体Polyclonal Antibody to Interleukin 23 (IL23)
kl384Mu01白介素23(IL23)多克隆抗体Polyclonal Antibody to Interleukin 23 (IL23)
kl384Ra01白介素23(IL23)多克隆抗体Polyclonal Antibody to Interleukin 23 (IL23)
kl385Hu01白介素27(IL27)多克隆抗体Polyclonal Antibody to Interleukin 27 (IL27)
kl385Ra01白介素27(IL27)多克隆抗体Polyclonal Antibody to Interleukin 27 (IL27)
kl389Mu01补体成分4a(C4a)多克隆抗体Polyclonal Antibody to Complement Component 4a (C4a)
kl389Ra01补体成分4a(C4a)多克隆抗体Polyclonal Antibody to Complement Component 4a (C4a)
kl391Hu01卵泡抑素(FS)多克隆抗体Polyclonal Antibody to Follistatin (FS)
kl391Mu01卵泡抑素(FS)多克隆抗体Polyclonal Antibody to Follistatin (FS)
kl392Hu01速激肽受体1(TACR1)多克隆抗体Polyclonal Antibody to Tachykinin Receptor 1 (TACR1)
kl394Hu01组织因子通道抑制因子(TFPI)多克隆抗体Polyclonal Antibody to Tissue Factor klhway Inhibitor (TFPI)
kl394Mu01组织因子通道抑制因子(TFPI)多克隆抗体Polyclonal Antibody to Tissue Factor klhway Inhibitor (TFPI)
kl394Ra01组织因子通道抑制因子(TFPI)多克隆抗体Polyclonal Antibody to Tissue Factor klhway Inhibitor (TFPI)
kl394Rb51组织因子通道抑制因子(TFPI)多克隆抗体Polyclonal Antibody to Tissue Factor klhway Inhibitor (TFPI)
kl395Hu01抑制素A(INHA)多克隆抗体Polyclonal Antibody to Inhibin A (INHA)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话